When the AIDS pandemic emerged in 1981, the diagnosis of AIDS was considered terminal. Over the four decades since then, advances in medicine have transformed HIV/AIDS into chronic and manageable—if still severe— condition. Despite this success, the annual incidence of HIV remains high, with 1.3 million new HIV infections worldwide and more than 30,000 in the United States.
The chapters in this illuminating and concise new manual suggest that this continued high incidence is driven at least in part a lack of a biopsychosocial approach to HIV prevention and care. The authors suggest that destigmatizing mental illness and integrating psychiatric aspects into multispecialty medical treatment, research, and public health policy are essential for the next level of meaningful progress in both prevention of HIV transmission and in the care of persons infected with and affected by HIV.
Drawing on the expertise of over 20 contributors, this book is organized into four key sections that examine
• Psychiatric screening, risk assessment, consultation, and evaluation in HIV care, including discussions of HIV testing, prevention, and stigma• Psychiatric illnesses associated with HIV infection, such as depressive, anxiety, substance-related and addictive, and neurocognitive disorders• The clinical management of psychiatric comorbidities in HIV-positive individuals, with attention to interactions between antiretrovirals and psychotropics, palliative and end-of-life care, and ethical considerations in HIV psychiatry • The challenges of providing HIV care against the backdrop of the COVID-19 pandemic and in resource-limited settings
Offering quick-reference tables and take-home points that distill key information, this clinically focused manual is an essential resource for infectious disease specialists, internists, pediatricians, psychiatrists, psychologists, nurses, and social workers who care for patients across the lifespan.
Drawing on the expertise of over 20 contributors, the book covers psychiatric screening and evaluation in HIV care; psychiatric disorders associated with HIV, such as substance-related and addictive, depressive, and neurocognitive disorders; and management strategies for addressing multimorbidities. It also explores providing HIV care in the context of the COVID-19 pandemic and in resource-limited settings.
